ClinConnect ClinConnect Logo
Search / Trial NCT04806958

The PulsePoint Study

Launched by DR. STEVEN BROOKS · Mar 16, 2021

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Cardiac Arrest Cardiopulmonary Resuscitation Automated External Defibrillators Smartphones

ClinConnect Summary

The PulsePoint Study is a research trial designed to see if a new system called PulsePoint can help increase the number of people who perform CPR or use a defibrillator when someone has a cardiac arrest outside of a hospital. In this study, half of the emergency calls for suspected cardiac arrest in public places will receive alerts through the PulsePoint system, while the other half will follow the usual emergency response procedures. The goal is to determine if the PulsePoint alerts lead to more people helping in these critical situations.

To participate in the trial, individuals must be involved in a 911 call that reports a suspected or confirmed cardiac arrest in a public location, where emergency medical services (EMS) are called to help. Unfortunately, those experiencing a cardiac arrest due to trauma, in dangerous situations, or in nursing homes and healthcare facilities won’t be eligible. If you or a loved one are in a situation where this study applies, the research team will provide more information about what being part of the study entails, including any support you’ll receive. This trial is currently looking for participants and welcomes individuals of all ages and genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients with 911 calls assigned as "suspected" or "confirmed" cardiac arrest and,
  • 2. Are confirmed to be EMS-treated, public location out-of-hospital cardiac arrest.
  • Exclusion Criteria:
  • 1. Traumatic cardiac arrest, or
  • 2. Cardiac arrests occurring in the context of a dangerous scene as determined by the 9-1-1 call-taker, or
  • 3. EMS-witnessed cardiac arrest, or
  • 4. Cardiac arrests not treated by EMS ("Do Not Resuscitate", signs of obvious death), or
  • 5. Cardiac arrests occurring in nursing homes and health care facilities.

About Dr. Steven Brooks

Dr. Steven Brooks is a distinguished clinical trial sponsor with extensive expertise in the design and management of innovative research studies. With a strong background in clinical medicine and a commitment to advancing healthcare through rigorous scientific inquiry, Dr. Brooks oversees a portfolio of trials that focus on developing novel therapies and improving patient outcomes. His collaborative approach fosters partnerships with leading research institutions and healthcare professionals, ensuring adherence to the highest ethical standards and regulatory compliance. Dr. Brooks is dedicated to translating research findings into practical applications that benefit patients and enhance the overall quality of care.

Locations

Columbus, Ohio, United States

Vancouver, British Columbia, Canada

Winnipeg, Manitoba, Canada

Patients applied

0 patients applied

Trial Officials

Steven C Brooks, MD MHSc

Principal Investigator

Queen's University

John M Tallon, MD MSc

Principal Investigator

University of British Columbia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials